Researchers from the University of Jyväskylä in collaboration with the Institute of Biomedicine University of Turku and Nova Central Finland have developed an artificial intelligence tool for automatic colorectal cancer tissue analysis.
Johnson & Johnson agrees to acquire Ambrx Biopharma for $2bn
Share this article The acquisition of Ambrx by Johnson & Johnson is anticipated to conclude in the first half of 2024. Credit: josefkubes / Shutterstock.com.